William Pullman MD PhD FRACP

William Pullman MD PhD FRACP has over 25 years of experience in the medical field. William began their career in 1995 at Eli Lilly as the Director of Medical Affairs. In 2001, they moved to Aventis as the Global Head of Clinical Discovery. In 2005, they joined Transform Pharmaceuticals as the Senior Vice President of Head Development. In 2006, they were hired by Cubist Pharmaceuticals as the Senior Vice President and Chief Medical Officer. In 2007, they became the Executive Vice President and Chief Research and Development Officer at Dyax Corp. In 2012, they were appointed Chief Scientific Officer at Upsher-Smith Laboratories, LLC. In 2017, they became President of Proximagen LLC. In 2020, they joined SmartPharm Therapeutics, Inc. as the Head of Research and Development, and they are currently a BioBridges Professional.

William Pullman MD PhD FRACP received their Doctor of Philosophy - PhD in Medicine and Clinical Science from The Australian National University in 1988. Prior to that, they obtained a BMedSc MB BS in Physiology and Medicine from The University of Western Australia in 1980. Their educational journey began in 1973 at The Royal Belfast Academical Institution.